2401 related articles for article (PubMed ID: 18164918)
1. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
2. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
6. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
[TBL] [Abstract][Full Text] [Related]
7. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
8. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT
Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
[TBL] [Abstract][Full Text] [Related]
9. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
Silberstein SD; Armellino JJ; Hoffman HD; Battikha JP; Hamelsky SW; Stewart WF; Lipton RB
Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
[TBL] [Abstract][Full Text] [Related]
10. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
Miner JR; Smith SW; Moore J; Biros M
Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
[TBL] [Abstract][Full Text] [Related]
11. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan.
Solbach MP; Waymer RS
Obstet Gynecol; 1993 Nov; 82(5):769-72. PubMed ID: 8414324
[TBL] [Abstract][Full Text] [Related]
12. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
[TBL] [Abstract][Full Text] [Related]
13. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
14. Open label study of intranasal sumatriptan (Imigran) for footballer's headache.
McCrory P; Heywood J; Ugoni A
Br J Sports Med; 2005 Aug; 39(8):552-4. PubMed ID: 16046342
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
16. Acute migraine treatment: patterns of use and satisfaction in a clinical population.
Malik SN; Hopkins M; Young WB; Silberstein SD
Headache; 2006 May; 46(5):773-80. PubMed ID: 16643580
[TBL] [Abstract][Full Text] [Related]
17. The Sinus, Allergy and Migraine Study (SAMS).
Eross E; Dodick D; Eross M
Headache; 2007 Feb; 47(2):213-24. PubMed ID: 17300361
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
19. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
Winner P; Landy S; Richardson M; Ames M
Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults.
Winner P; Adelman J; Aurora S; Lener ME; Ames M
Clin Ther; 2006 Oct; 28(10):1582-91. PubMed ID: 17157114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
